The expected global late stage chronic kidney disease therapeutics industry share in 2019 was US$ 4.7 billion. However, the global market for treatments for late-stage renal disease is anticipated to reach US$ 11.1 billion in 2027 and expand at a strong CAGR of almost 11.6% over the course of the forecast period due to the …